Advanced search
Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 31, 2024 - Issue 2
Submit an article Journal homepage
54
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Symptomatic SARS-CoV2 infection associated with high mortality in AA amyloidosis

Rim Bourguibaa Internal Medicine Department, Tenon Hospital, AP-HP, Paris, France;b National French Reference Center for Autoinflammatory Diseases and AA Amyloidosis, Paris, FranceORCID Iconhttps://orcid.org/0000-0002-7352-9074View further author information
ORCID Icon,
Alexandre Terréa Internal Medicine Department, Tenon Hospital, AP-HP, Paris, France;b National French Reference Center for Autoinflammatory Diseases and AA Amyloidosis, Paris, FranceORCID Iconhttps://orcid.org/0000-0002-8295-9068View further author information
ORCID Icon,
Lea Saveya Internal Medicine Department, Tenon Hospital, AP-HP, Paris, France;b National French Reference Center for Autoinflammatory Diseases and AA Amyloidosis, Paris, FranceORCID Iconhttps://orcid.org/0000-0002-1989-1304View further author information
ORCID Icon,
Eric Oziolc Internal Medicine Department, Béziers Hospital, Béziers, FranceView further author information
,
Thomas Hanslikd Internal Medicine Department, Ambroise Paré Hospital, APHP, Paris, FranceView further author information
,
Jean-Emmanuel Kahnd Internal Medicine Department, Ambroise Paré Hospital, APHP, Paris, FranceView further author information
,
Raphael Boriee Pneumology Department, Bichat Hospital, AP-HP, Paris, FranceView further author information
,
Alexandre Cezf Nephrology Department, Tenon hospital, AP-HP, Paris, FranceView further author information
,
David Buobb National French Reference Center for Autoinflammatory Diseases and AA Amyloidosis, Paris, France;g Anatomopathology Department, Tenon Hospital, AP-HP, Paris, France;h Sorbonne University, Paris, FranceView further author information
,
Gilles Grateaua Internal Medicine Department, Tenon Hospital, AP-HP, Paris, France;b National French Reference Center for Autoinflammatory Diseases and AA Amyloidosis, Paris, FranceView further author information
,
Jean-Jacques Boffab National French Reference Center for Autoinflammatory Diseases and AA Amyloidosis, Paris, France;f Nephrology Department, Tenon hospital, AP-HP, Paris, France;h Sorbonne University, Paris, FranceView further author information
&
Sophie Georgin-Laviallea Internal Medicine Department, Tenon Hospital, AP-HP, Paris, France;b National French Reference Center for Autoinflammatory Diseases and AA Amyloidosis, Paris, France;h Sorbonne University, Paris, FranceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6668-8854View further author information
ORCID Icon show all
Pages 156-158 | Received 28 Jul 2023, Accepted 08 Dec 2023, Published online: 21 Dec 2023

References

  • Akalin E, Azzi Y, Bartash R, et al. Covid-19 and kidney transplantation. N Engl J Med. 2020;382(25):2475–2477. doi: 10.1056/NEJMc2011117.
  • Kastritis E, Wechalekar A, Schönland S, et al. Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic. Br J Haematol. 2020;190(3):346–357. doi: 10.1111/bjh.16898.
  • Lewis E, Fine N, Miller RJH, et al. Amyloidosis and COVID-19: experience from an amyloid program in Canada. Ann Hematol. 2022;101(10):2307–2315. doi: 10.1007/s00277-022-04964-y.
  • Li H, Xiang X, Ren H, et al. Serum amyloid a is a biomarker of severe coronavirus disease and poor prognosis. J Infect. 2020;80(6):646–655. doi: 10.1016/j.jinf.2020.03.035.
  • Mir TH, Zargar PA, Sharma A, et al. Post COVID-19 AA amyloidosis of the kidneys with rapidly progressive renal failure. Prion. 2023;17(1):111–115. doi: 10.1080/19336896.2023.2201151.
  • Prendecki M, Clarke C, Edwards H, et al. Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression. Ann Rheum Dis. 2021;80(10):1322–1329. doi: 10.1136/annrheumdis-2021-220626.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.